Sirona Financial Statements From 2010 to 2024

SBM Stock  CAD 0.07  0.01  13.33%   
Sirona Biochem financial statements provide useful quarterly and yearly information to potential Sirona Biochem Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sirona Biochem financial statements helps investors assess Sirona Biochem's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sirona Biochem's valuation are summarized below:
Gross Profit
621.8 K
Market Capitalization
16.8 M
Enterprise Value Revenue
447.502
Revenue
-16.4 K
Earnings Share
(0.01)
There are over seventy-five available fundamental trend indicators for Sirona Biochem Corp, which can be analyzed over time and compared to other ratios. All traders should should double-check Sirona Biochem's current fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable.

Sirona Biochem Total Revenue

37,996.06

Check Sirona Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sirona Biochem's main balance sheet or income statement drivers, such as Interest Expense of 243.5 K, Selling General Administrative of 1 M or Total Revenue of 38 K, as well as many indicators such as . Sirona financial statements analysis is a perfect complement when working with Sirona Biochem Valuation or Volatility modules.
  
This module can also supplement various Sirona Biochem Technical models . Check out the analysis of Sirona Biochem Correlation against competitors.

Sirona Biochem Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets882.4 K928.9 K2.3 M
Slightly volatile
Other Current Liabilities103.5 K201.6 K109.1 K
Slightly volatile
Total Current Liabilities2.3 M2.1 M1.1 M
Slightly volatile
Other Liabilities117.8 K132.4 K110 K
Pretty Stable
Accounts Payable1.3 M1.3 M505.2 K
Slightly volatile
Cash987 K657.2 K887.2 K
Pretty Stable
Long Term Debt1.9 M1.8 M829.8 K
Slightly volatile
Net Receivables5.6 K5.9 K302.4 K
Slightly volatile
Short Term Investments62866157.7 K
Slightly volatile
Other Current Assets8.4 K8.8 K17.5 K
Slightly volatile
Total Liabilities2.1 M4.1 MM
Slightly volatile
Deferred Long Term Liabilities316 K371.1 K399.7 K
Slightly volatile
Short and Long Term Debt536.1 K733.3 K507 K
Slightly volatile
Total Current Assets1.7 M1.2 M1.5 M
Very volatile
Short Term Debt586.1 K537.9 K519.4 K
Slightly volatile
Intangible Assets1.4 M1.4 M1.6 M
Slightly volatile
Common Stock21.5 M39.7 M22 M
Slightly volatile
Property Plant Equipment16 K16.9 K51.1 K
Slightly volatile
Non Current Liabilities Total897.2 K1.5 M1.1 M
Very volatile
Capital Lease ObligationsK5.3 K150.1 K
Slightly volatile
Net Debt1.2 M1.4 M1.4 M
Slightly volatile
Common Stock Shares Outstanding242.2 M291.6 M206.3 M
Slightly volatile
Capital Stock32.7 M39.9 M26.2 M
Slightly volatile
Property Plant And Equipment Net7.7 K8.1 K29.6 K
Slightly volatile

Sirona Biochem Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General AdministrativeM1.1 M1.9 M
Pretty Stable
Other Operating Expenses782773872
Slightly volatile
Research Development1.1 M1.4 MM
Slightly volatile
Non Recurring51.8 K54.6 K79.1 K
Slightly volatile
Total Operating Expenses3.5 M2.8 M3.2 M
Pretty Stable

Sirona Biochem Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of StockM1.2 M1.8 M
Slightly volatile
Depreciation8.3 K8.7 K57.5 K
Slightly volatile
Change To NetincomeM1.9 MM
Slightly volatile
End Period Cash Flow826.6 K514.3 K844.9 K
Very volatile
Begin Period Cash Flow460.5 K484.7 K821.3 K
Pretty Stable
Other Non Cash Items123.8 K222.4 K87.3 K
Slightly volatile
Stock Based Compensation26.1 K27.5 K867.7 K
Slightly volatile

About Sirona Biochem Financial Statements

Sirona Biochem investors use historical fundamental indicators, such as Sirona Biochem's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sirona Biochem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue40 K38 K
Cost Of Revenue65.4 K34.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sirona Stock Analysis

When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.